ATE460154T1 - Bioresorbierbare zusammensetzung mit kontrollierter freisetzung - Google Patents

Bioresorbierbare zusammensetzung mit kontrollierter freisetzung

Info

Publication number
ATE460154T1
ATE460154T1 AT07711943T AT07711943T ATE460154T1 AT E460154 T1 ATE460154 T1 AT E460154T1 AT 07711943 T AT07711943 T AT 07711943T AT 07711943 T AT07711943 T AT 07711943T AT E460154 T1 ATE460154 T1 AT E460154T1
Authority
AT
Austria
Prior art keywords
ceramic
pharmaceutical composition
preparation
controlled
controlled release
Prior art date
Application number
AT07711943T
Other languages
English (en)
Inventor
Niklas Axen
Hans Lennernaes
Original Assignee
Lidds Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lidds Ab filed Critical Lidds Ab
Application granted granted Critical
Publication of ATE460154T1 publication Critical patent/ATE460154T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT07711943T 2006-03-14 2007-03-14 Bioresorbierbare zusammensetzung mit kontrollierter freisetzung ATE460154T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200600361 2006-03-14
PCT/EP2007/002250 WO2007104549A2 (en) 2006-03-14 2007-03-14 Bioresorbable controlled-release composition

Publications (1)

Publication Number Publication Date
ATE460154T1 true ATE460154T1 (de) 2010-03-15

Family

ID=36602790

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07711943T ATE460154T1 (de) 2006-03-14 2007-03-14 Bioresorbierbare zusammensetzung mit kontrollierter freisetzung

Country Status (18)

Country Link
US (1) US8999389B2 (de)
EP (1) EP1996160B8 (de)
JP (1) JP5216601B2 (de)
KR (1) KR101378174B1 (de)
CN (1) CN101431984B (de)
AT (1) ATE460154T1 (de)
AU (1) AU2007224651B8 (de)
CA (1) CA2644429C (de)
DE (1) DE602007005231D1 (de)
DK (1) DK1996160T3 (de)
ES (1) ES2342123T3 (de)
HK (1) HK1129061A1 (de)
IL (1) IL193973A (de)
MX (1) MX2008011606A (de)
PL (1) PL1996160T3 (de)
RU (1) RU2405537C2 (de)
WO (1) WO2007104549A2 (de)
ZA (1) ZA200807881B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL181834A (en) 2006-04-02 2011-04-28 Iscar Ltd Cutting head and adaptor
JP5702294B2 (ja) * 2008-11-27 2015-04-15 リッズ エービーＬｉｄｄｓ Ａｂ 一以上の生物吸収性セラミックを含む組成物の吐出性および凝固時間を制御するための、カルボキシメチルセルロースの使用
US20110313052A1 (en) * 2009-02-12 2011-12-22 Aduro Material Ab Composition Comprising Biodegradable Carrier for Controlled Delivery
JP6546923B2 (ja) * 2013-12-23 2019-07-17 ビーシーエヌ ペプタイズ エセ．ア．Ｂｃｎ Ｐｅｐｔｉｄｅｓ Ｓ．Ａ． リソソーム蓄積障害または糖原病の処置における使用のためのエキソサイトーシス活性化化合物としてのビカルタミド類似体または（ｓ）−ビカルタミド
RU2750163C2 (ru) 2015-06-04 2021-06-22 Крититек, Инк. Таксановые частицы и их применение
WO2017176628A1 (en) 2016-04-04 2017-10-12 Crititech, Inc. Methods for solid tumor treatment
US10351437B2 (en) 2016-10-17 2019-07-16 Lidds Ab Method for producing calcium sulphate hemihydrate with unique properties
BR112019023948A2 (pt) 2017-06-09 2020-06-09 Crititech Inc tratamento de cistos epiteliais por injeção intracística de partículas antineoplásicas
KR102303762B1 (ko) 2017-06-14 2021-09-23 크리티테크, 인크. 폐 장애의 치료 방법
WO2019070850A1 (en) 2017-10-03 2019-04-11 Crititech, Inc. LOCAL ADMINISTRATION OF ANINEOPLASTIC PARTICLES IN COMBINATION WITH SYSTEMIC DELIVERY OF IMMUNOTHERAPEUTIC AGENTS FOR THE TREATMENT OF CANCER
RU2683255C1 (ru) * 2018-03-06 2019-03-27 Федеральное государственное бюджетное учреждение науки Институт химии твердого тела Уральского отделения Российской академии наук Биоактивный композиционный материал для замещения костных дефектов и способ его получения
WO2019170912A1 (en) 2018-03-09 2019-09-12 Lidds Ab Bioresorbable controlled-release compositions with sting modulating molecules

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3797758A (en) * 1972-06-16 1974-03-19 Giulini Gmbh Geb Method of producing finely dispersed alpha calcium sulfate hemihydrate
JP2702953B2 (ja) 1988-01-30 1998-01-26 オリンパス光学工業株式会社 薬液含浸セラミックス
EP0376331A3 (de) 1988-12-29 1991-03-13 Asahi Kogaku Kogyo Kabushiki Kaisha Granula zur langsamen Wirkstoffabgabe sowie Verfahren zu deren Herstellung
US5614206A (en) * 1995-03-07 1997-03-25 Wright Medical Technology, Inc. Controlled dissolution pellet containing calcium sulfate
US8333996B2 (en) 1995-05-19 2012-12-18 Etex Corporation Calcium phosphate delivery vehicle and adjuvant
US6132463A (en) 1995-05-19 2000-10-17 Etex Corporation Cell seeding of ceramic compositions
JP4260891B2 (ja) * 1996-10-16 2009-04-30 エテックス コーポレイション 生体セラミック組成物
US6391336B1 (en) * 1997-09-22 2002-05-21 Royer Biomedical, Inc. Inorganic-polymer complexes for the controlled release of compounds including medicinals
US6030635A (en) * 1998-02-27 2000-02-29 Musculoskeletal Transplant Foundation Malleable paste for filling bone defects
GB0020610D0 (en) 2000-08-21 2000-10-11 Dytech Corp Ltd Uses of porous carriers
US6730324B2 (en) * 2001-04-20 2004-05-04 The University Of British Columbia Biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation
SE522749C2 (sv) * 2002-03-04 2004-03-02 Cerbio Tech Ab Ytbeläggningsförfarande, ytbelagd anordning och biokompatibel ytbeläggning
EP1680089B1 (de) 2003-10-22 2013-09-11 Lidds AB Zusammensetzung mit biologisch abbaubaren hydrierenden keramikstoffen für die kontrollierte arzneimittelabgabe

Also Published As

Publication number Publication date
EP1996160B1 (de) 2010-03-10
ZA200807881B (en) 2009-10-28
KR101378174B1 (ko) 2014-03-27
DE602007005231D1 (de) 2010-04-22
AU2007224651B8 (en) 2011-10-27
MX2008011606A (es) 2008-09-22
ES2342123T3 (es) 2010-07-01
IL193973A (en) 2012-07-31
AU2007224651B2 (en) 2011-10-13
US20090118215A1 (en) 2009-05-07
PL1996160T3 (pl) 2010-09-30
AU2007224651A1 (en) 2007-09-20
HK1129061A1 (en) 2009-11-20
WO2007104549A2 (en) 2007-09-20
JP2009529554A (ja) 2009-08-20
KR20080108128A (ko) 2008-12-11
CN101431984A (zh) 2009-05-13
CA2644429C (en) 2014-07-29
AU2007224651A8 (en) 2011-10-27
WO2007104549A8 (en) 2007-12-13
CA2644429A1 (en) 2007-09-20
JP5216601B2 (ja) 2013-06-19
CN101431984B (zh) 2013-07-10
DK1996160T3 (da) 2010-07-05
RU2008140519A (ru) 2010-04-20
US8999389B2 (en) 2015-04-07
EP1996160A2 (de) 2008-12-03
IL193973A0 (en) 2009-09-22
WO2007104549A3 (en) 2007-11-08
EP1996160B8 (de) 2010-05-12
RU2405537C2 (ru) 2010-12-10

Similar Documents

Publication Publication Date Title
ATE460154T1 (de) Bioresorbierbare zusammensetzung mit kontrollierter freisetzung
WO2006099268A3 (en) Cgrp receptor antagonists
IL182317A0 (en) Cgrp receptor antagonists
DK2321321T3 (da) Triazolo [4,5-d]pyramidinderivater og anvendelse deraf som purinreceptorantagonister
WO2006029153A3 (en) Monocyclic anilide spirolactam cgrp receptor antagonists
BRPI0715893A2 (pt) composto de azetidina e uso para a preparaÇço de um medicamento para a prevenÇço ou tratamento de distérbios distÍmicos ou do sono
NO20070487L (no) 3-aminocyklopentankarboksamider som modulatorer av kjemokinreseptorer.
RS51563B (en) PHARMACEUTICAL COMPOSITIONS CONTAINING ROOSUVASTATIN CALCIUM
MY156822A (en) Indole derivatives as s1p1 receptor agonists
ATE482210T1 (de) Oxadiazolderivate als s1p1-rezeptor-agonisten
WO2006031610A3 (en) Bicyclic anilide spirolactam cgrp receptor antagonists
UY31209A1 (es) Uso de homo y copolimeros para la estabilización de formulaciones de principios activos
WO2008112159A3 (en) Monocyclic anilide spirolactam cgrp receptor antagonists
WO2006031491A3 (en) Tricyclic anilide spirolactam cgrp receptor antagonists
WO2006004741A3 (en) 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
NO20084826L (no) Ny administrasjonsform av racecadotril
CL2008003067A1 (es) Compuesto 2-[3-(2,2-difluoro-benzo[1,3]dioxol-5-ilamino)-5-(2,6-dimetil-piridin-4-il)-[1,2,4]triazol-1-il]-n-etil-acetamida, modulador de receptores nicotinicos alfa-7; proceso de preparacion; composicion farmaceutica y su proceso de preparacion; y su uso en el tratamiento de trastornos psicoticos, intelectuales, inflamatorios.
WO2008048801A3 (en) Phenylalkylamino carbamate compositions
DK2018169T3 (da) Anvendelse af 4,17-beta-dihydroxyandrost-4-en-3-on til behandling af cancer
WO2007072201A3 (en) 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
WO2006047196A3 (en) Cgrp receptor antagonists
CL2008003659A1 (es) Compuestos derivados de 6-(4-bencilpiperazin-1-il)pirimidin-4-ona, moduladores de la enzima estearoil-coa-desaturasa 1; procedimiento de preparacion; composicin farmaceutica; y uso en el tratamiento y profilaxis de la obesidad.
WO2005115392A3 (en) 3-(4-heteroarylcyclohexylamino) cyclopentanecarboxamides as modulators of chemokine receptors
WO2006031676A3 (en) Tricyclic anilide spirohydantoin cgrp receptor antagonists
EA200970378A1 (ru) Композиции фенилалкилкарбамата

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties